nach oben

Metabolic Brain Disease

Erschienen in:

05.03.2020 | Original Article

MicroRNA-216a inhibits neuronal apoptosis in a cellular Parkinson’s disease model by targeting Bax

verfasst von: Xiaobo Yang, Meng Zhang, Meng Wei, Anqi Wang, Yongning Deng, Hongmei Cao

Erschienen in: Metabolic Brain Disease | Ausgabe 4/2020

Einloggen, um Zugang zu erhalten

Abstract

The study found that microRNAs play an important role in Parkinson’s disease (PD). However, the function of MicroRNA-216a (miR-216a) in PD is unclear. Therefore, this experiment aimed to investigate the pathogenesis of miR-216a in PD. Using the toxicity of MPP+ to polyhexamine neurons, apoptosis of SH-SY5Y neuroblastoma cells was induced at different time by MPP+ to construct a stable acute PD cell model. The effects of DNA breakage, mitochondrial membrane potential (A ^ m), caspase-3 activity and nucleosome enrichment on cell apoptosis were detected by flow cytometry, TUNEL. MPP+ increased the toxic effects of dopaminergic neurons in a PD model. The introduction of miR-216a inhibited MPP + -induced neuronal apoptosis. The main manifestations were the decreased levels of positive rate of Tunel cells, caspase 3 activity and nucleosome enrichment factor. Bax was a direct target of miR-216a. In addition, Bax overexpression reversed the effects of miR-216a on neural cells. Bax downstream factors were also involved in miR-216a regulation of MPP + -triggered neuronal apoptosis. miR-216a regulated the progression of PD by regulating Bax, and miR-216a may be a potential target for PD.

Akh A, Filatova EV, Karabanov AV et al (2015) miRNA expression is highly sensitive to a drug therapy in Parkinson's disease. Parkinsonism Relat Disord 21(1):72–74CrossRef

Armstrong RA (2017) Visual dysfunction in Parkinson's disease. Int Rev Neurobiol 134(6):921–946PubMedCrossRef

Bai X, Tang Y, Yu M, Wu L, Wang J (2017) Downregulation of blood serum microRNA 29 family in patients with Parkinson’s disease. Sci Rep 7(1):5411PubMedPubMedCentralCrossRef

Cai X, Jia H, Liu Z et al (2010) Polyhydroxylated fullerene derivative C60(OH)24 prevents mitochondrial dysfunction and oxidative damage in an MPP+-induced cellular model of Parkinson's disease. J Neurosci Res 86(16):3622–3634CrossRef

Caneda-Ferrón B, Girolamo LAD, Costa T, Beck KE, Layfield R, Billett EE (2010) Assessment of the direct and indirect effects of MPP+ and dopamine on the human proteasome: implications for Parkinson’s disease aetiology. J Neurochem 105(1):225–238CrossRef

Casas S, García S, Cabrera R, Nanfaro F, Escudero C, Yunes R (2011) Progesterone prevents depression-like behavior in a model of Parkinson's disease induced by 6-hydroxydopamine in male rats. Pharmacol Biochem Behav 99(4):614–618PubMedCrossRef

Chang D, Nalls MA, Hallgrímsdóttir IB, Hunkapiller J, van der Brug M, Cai F, International Parkinson's Disease Genomics Consortium, 23andMe Research Team, Kerchner GA, Ayalon G, Bingol B, Sheng M, Hinds D, Behrens TW, Singleton AB, Bhangale TR, Graham RR (2017) A meta-analysis of genome-wide association studies identifies 17 new Parkinson's disease risk loci. Nat Genet 49(10):1511–1516PubMedPubMedCentralCrossRef

Chaudhuri KR, Healy DG, Schapira AH (2017) Non-motor symptoms of Parkinson's disease: diagnosis and management. Lancet Neurol 5(3):235–245CrossRef

Da SF, Iop RD, Vietta GG et al (2016) microRNAs involved in Parkinson's disease: a systematic review. Mol Med Rep 14(5):4015–4022CrossRef

Delavar MR, Baghi M, Yadegari E, Ghaedi K. Bioinformatic Prediction and Introducing of Some Targeting MicroRNAs of Sirt1 and Bcl2 Genes in Model of Parkinson's Disease. Majallah-i dānishgāh-i ̒ulūm-i pizishkī-i Arāk. 2017

Dong S, Huiqing Y, Cuicui D et al (2017) Corrigendum to “Predictive value of plasma MicroRNA-216a/b in the diagnosis of esophageal squamous cell carcinoma”. Dis Markers 2017:1–2

Dunnewold RJ, Jacobi CE, van Hilten JJ (2018) Quantitative assessment of bradykinesia in patients with Parkinson's disease. J Clin Neurosurg 74(1):107

Falco MD, Luca LD, Acanfora F et al (2001) Alteration of the Bcl-2 : Bax Ratio in the placenta as pregnancy proceeds. Histochem J 33(7):421–425PubMedCrossRef

Falup-Pecurariu C, Diaconu Ş (2017) Sleep dysfunction in Parkinson's disease. Int Rev Neurobiol 47(1):35

Guénin S, Mauriat M, Pelloux J, Wuytswinkel OV, Bellini C, Gutierrez L (2009) Normalization of qRT-PCR data: the necessity of adopting a systematic, experimental conditions-specific, validation of references. J Exp Bot 60(2):487–493PubMedCrossRef

Harraz MM, Dawson TM, Dawson VL (2012) MicroRNAs in Parkinson's disease. J Chem Neuroanat 46(2):279–284

Hartmann A, Michel PP, Troadec JD et al (2001) Is Bax a mitochondrial mediator in apoptotic death of dopaminergic neurons in Parkinson's disease?&nbsp. J Neurochem 76(6):1785–1793PubMedCrossRef

He X, Yu Y, Awatramani R, Lu QR (2012) Unwrapping myelination by microRNAs. Neuroscientist 18(1):45PubMedCrossRef

Jung YW, Zindl CL, Lai JF, Weaver CT, Chaplin DD (2010) MMP induced by Gr-1+ cells are crucial for recruitment of Th cells into the airways. Eur J Immunol 39(8):2281–2292CrossRef

Kim C, Ojoamaize E, Spencer B et al (2015) Hypoestoxide reduces neuroinflammation and α-synuclein accumulation in a mouse model of Parkinson’s disease. J Neuroinflammation 12(1):236PubMedPubMedCentralCrossRef

Kuhar MJ, Yoho LL (2015) CART peptide analysis by Western blotting. Synapse 33(3):163–171CrossRef

Leggio L, Vivarelli S, L'Episcopo F et al (2017) microRNAs in Parkinson's disease: from pathogenesis to novel diagnostic and therapeutic approaches. Int J Mol Sci 18(12):2698PubMedCentralCrossRef

Lewis TB, Glasgow JN, Harms AS, Standaert DG, Curiel DT (2014) Fiber-modified adenovirus for central nervous system Parkinson's disease gene therapy. Viruses 6(8):3293–3310PubMedPubMedCentralCrossRef

Liu C, Xi G, Yan P, Zhang W, Tang Y (2004) Effect of scorpion venom on the expression of Bcl-2/Bax in dopaminergic neurons of PD mice. Neuroscientist 24:623–628

Marconi R, Lefebvrecaparros D, Bonnet AM, Vidailhet M, Dubois B, Agid Y (2010) Levodopa-induced dyskinesias in Parkinson's disease phenomenology and pathophysiology. Mov Disord 9(1):2–12CrossRef

Mei JM, Niu CS (2014) Effects of CDNF on 6-OHDA-induced apoptosis in PC12 cells via modulation of Bcl-2/Bax and caspase-3 activation. Neurol Sci 35(8):1275–1280PubMedCrossRef

Menghini R, Casagrande V, Marino A et al (2017) MiR-216a: a link between endothelial dysfunction and autophagy. Cell Death Dis 5(1):e1029

Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O'Briant KC, Allen A, Lin DW, Urban N, Drescher CW, Knudsen BS, Stirewalt DL, Gentleman R, Vessella RL, Nelson PS, Martin DB, Tewari M (2008) Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A 105(30):10513–10518PubMedPubMedCentralCrossRef

O'Connor L, Strasser A, O'Reilly LA et al (2014) Bim: a novel member of the Bcl-2 family that promotes apoptosis. EMBO J 17(2):384–395CrossRef

Onyango IG (2008) Mitochondrial dysfunction and oxidative stress in Parkinson’s disease. Neurochem Res 33(3):589–597PubMedCrossRef

Pang X, Hogan EM, Casserly A, Gao G, Gardner PD, Tapper AR (2014) Dicer expression is essential for adult midbrain dopaminergic neuron maintenance and survival. Mol Cell Neurosci 58(1):22–28PubMedCrossRef

Reed JC (2006) Proapoptotic multidomain Bcl-2/Bax-family proteins: mechanisms, physiological roles, and therapeutic opportunities. Cell Death Differ 13(8):1378–1386PubMedCrossRef

Rodriguezoroz MC, Jahanshahi M, Krack P et al (2009) Initial clinical manifestations of Parkinson's disease: features and pathophysiological mechanisms. Lancet Neurol 8(12):1128–1139CrossRef

Singleton AB, Farrer M, Johnson J et al (2003) Alpha-Synuclein locus triplication causes Parkinson's disease. Science 302(5646):841–841PubMedCrossRef

Staudt MD, Di SA, Xu H et al (2015) Advances in Neurotrophic factor and cell-based therapies for Parkinson's disease: a mini-review. Gerontology 62(3):371–380PubMedCrossRef

Suh DC, Pahwa R, Mallya U (2012) Treatment patterns and associated costs with Parkinson's disease levodopa induced dyskinesia. J Neurol Sci 319(1–2):24–31PubMedCrossRef

Titzedealmeida R, Titzedealmeida SS (2018) miR-7 replacement therapy in Parkinson's disease. Curr Gene Ther 18(3):143–153

Tolosa E, Bottaorfila T, Morató X et al (2018) MicroRNA alterations in iPSC-derived dopaminergic neurons from Parkinson disease patients. Neurobiol Aging 4(5):eaao5553

Wang Z, Li Y, Kong D, Ahmad A, Banerjee S, Sarkar FH (2010) Cross-talk between miRNA and notch signaling pathways in tumor development and progression. Cancer Lett 292(2):141–148PubMedCrossRef

Wang DB, Uo T, Kinoshita C et al (2017) Bax interacting Factor-1 promotes survival and mitochondrial elongation in neurons. J Neurosci the Official Journal of the Society for Neuroscience 34(7):2674–2683

Willis AW, Schootman M, Kung N, Racette BA (2013) Epidemiology and neuropsychiatric manifestations of young onset Parkinson’s disease in the United States. Parkinsonism Relat Disord 19(2):202–206PubMedCrossRef

Xiao M, Li J, Li W, Wang Y, Wu F, Xi Y, Zhang L, Ding C, Luo H, Li Y, Peng L, Zhao L, Peng S, Xiao Y, Dong S, Cao J, Yu W (2017) MicroRNAs activate gene transcription epigenetically as an enhancer trigger. RNA Biol 14(10):1326–1334PubMedCrossRef

Xie Y, Chen Y (2016) microRNAs: emerging targets regulating oxidative stress in the models of Parkinson's disease. Front Neurosci 10

Yang B, Gao G, Wang Z, et al (2018) Long non-coding RNA HOTTIP promotes prostate cancer cells proliferation and migration by sponging miR-216a-5p. Biosci Rep 38(5):BSR20180566

Zhao N, Jin L, Fei G, Zheng Z, Zhong C (2014) Serum microRNA-133b is associated with low ceruloplasmin levels in Parkinson's disease. Parkinsonism Relat Disord 20(11):1177–1180PubMedCrossRef

Zou XZ, Liu T, Gong ZC, Hu CP, Zhang Z (2017) MicroRNAs-mediated epithelial-mesenchymal transition in fibrotic diseases. Eur J Pharmacol 796:190–206PubMedCrossRef

Titel: MicroRNA-216a inhibits neuronal apoptosis in a cellular Parkinson’s disease model by targeting Bax
verfasst von: Xiaobo Yang
Meng Zhang
Meng Wei
Anqi Wang
Yongning Deng
Hongmei Cao
Publikationsdatum: 05.03.2020
Verlag: Springer US
Erschienen in: Metabolic Brain Disease / Ausgabe 4/2020
Print ISSN: 0885-7490
Elektronische ISSN: 1573-7365
DOI: https://doi.org/10.1007/s11011-020-00546-x

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

25.04.2024 | Hypotonie | Nachrichten

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

MicroRNA-216a inhibits neuronal apoptosis in a cellular Parkinson’s disease model by targeting Bax

Abstract

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Demenzkranke durch Antipsychotika vielfach gefährdet

Parkinson-Therapie im Wandel – aktuelle Leitlinie im Fokus

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

Update Neurologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2020

Curcumin attenuates cytoplasmic/endoplasmic reticulum stress, apoptosis and cholinergic dysfunction in diabetic rat hippocampus

Amnesia-ameliorative effect of a quinoline derivative through regulation of oxidative/cholinergic systems and Na+/K+-ATPase activity in mice

Post-mortem tissue analyses in a patient with succinic semialdehyde dehydrogenase deficiency (SSADHD). I. Metabolomic outcomes

Astrocyte swelling in hepatic encephalopathy: molecular perspective of cytotoxic edema

Pachymic acid protects against cerebral ischemia/reperfusion injury by the PI3K/Akt signaling pathway

Dihydroartemisinin ameliorates LPS-induced neuroinflammation by inhibiting the PI3K/AKT pathway

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Demenzkranke durch Antipsychotika vielfach gefährdet

Parkinson-Therapie im Wandel – aktuelle Leitlinie im Fokus

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

Update Neurologie